Reliable access to quality-assured antiretroviral medicines is an important part of maintaining continuity of HIV treatment and healthcare services. Global Pharma Trade supplies Abacavir + Dolutegravir + Lamivudine 600mg/50mg/300mg tablets for qualified pharmaceutical buyers, hospitals, healthcare providers, distributors and institutional procurement channels in South Africa, subject to applicable regulatory requirements.
The combination contains three antiretroviral medicines: Abacavir 600mg, Dolutegravir 50mg and Lamivudine 300mg. The three-drug combination is commonly referred to as ABC + DTG + 3TC. WHO's HIV guidance recognizes dolutegravir-based regimens as an important preferred option for HIV treatment, while its HIV regimen resources include ABC + 3TC + DTG combinations.
Abacavir + Dolutegravir + Lamivudine 600mg/50mg/300mg Supply in South Africa
Global Pharma Trade supports pharmaceutical procurement requirements for Abacavir + Dolutegravir + Lamivudine 600mg/50mg/300mg from India for eligible buyers in South Africa.
The product may be relevant to procurement teams looking for:
- Abacavir + Dolutegravir + Lamivudine tablets
- ABC + DTG + 3TC fixed-dose combination
- Abacavir 600mg + Dolutegravir 50mg + Lamivudine 300mg
- HIV antiretroviral medicine supply
- Bulk pharmaceutical procurement
- Hospital and healthcare-provider supply
- Pharmaceutical distributor sourcing
- Institutional medicine procurement
Availability, product registration status, import authorization and supply arrangements should be confirmed before placing an order.
Supply for South African Hospitals and Healthcare Providers
Hospitals, clinics, healthcare organizations, pharmaceutical distributors and procurement companies may require consistent access to antiretroviral medicines for their approved treatment and supply programs.
Global Pharma Trade can discuss bulk requirements, commercial quotations, product documentation, packaging information and international shipment arrangements with qualified buyers.
For institutional procurement, buyers can provide:
- Required quantity
- Preferred pack size
- Delivery location in South Africa
- Importer or distributor details
- Required documentation
- Purchase timeline
- Any applicable regulatory requirements
This allows the supply proposal to be prepared according to the buyer's requirements.
Why Abacavir + Dolutegravir + Lamivudine Is Relevant to HIV Treatment
Abacavir, dolutegravir and lamivudine belong to different antiretroviral classes and can be combined as a three-drug HIV treatment regimen. WHO resources identify ABC + 3TC + DTG as an established antiretroviral regimen.
The fixed-dose combination brings multiple active ingredients together in one tablet, which can simplify pharmaceutical procurement and dispensing compared with sourcing each active ingredient separately.
However, treatment selection, prescribing and patient suitability must be determined by an appropriately qualified healthcare professional. This article is intended for pharmaceutical procurement and product information purposes and does not replace medical advice.
Pharmaceutical Supply from India to South Africa
For South African buyers sourcing medicines internationally, regulatory and documentation requirements should be considered before shipment.
SAHPRA regulates medicines and pharmaceutical establishments in South Africa. Its licensing framework covers activities including importing, exporting, wholesaling and distributing medicines and scheduled substances.
SAHPRA's importation guidance also addresses requirements relating to pharmaceutical quality systems, documentation, storage, transportation, temperature control and export documentation.
Therefore, buyers should verify that the intended product, importer, exporter and shipment comply with the applicable South African requirements before ordering.
Regulatory Compliance and Documentation
For pharmaceutical procurement into South Africa, regulatory requirements can vary according to the medicine, importer, intended use and applicable authorization pathway.
SAHPRA states that medicines available in South Africa must meet the applicable authorization requirements; certain unregistered medicines may require specific authorization under the relevant provisions, including Section 21 in applicable circumstances.
Depending on the transaction, buyers may require documentation such as:
- Commercial invoice
- Packing list
- Certificate of Analysis (CoA)
- Product information
- Batch and expiry information
- Manufacturer documentation
- Certificate of Pharmaceutical Product (CPP), where applicable
- Shipping documentation
- Regulatory/import documentation as applicable
Documentation should be confirmed with the South African importer and relevant regulatory authorities before shipment.
Bulk Abacavir + Dolutegravir + Lamivudine Procurement
For hospitals, distributors and healthcare procurement organizations, bulk purchasing can require advance planning around:
Product availability: Confirm the required strength, formulation, pack configuration and available batch.
Quantity: Share expected monthly, quarterly or annual requirements for quotation purposes.
Documentation: Confirm which quality and regulatory documents are required before purchase.
Shipping: Confirm the destination, delivery terms and applicable import procedures.
Regulatory status: Verify that the product and proposed importation pathway comply with South African requirements.
Global Pharma Trade can discuss these requirements with qualified pharmaceutical buyers seeking Abacavir + Dolutegravir + Lamivudine 600mg/50mg/300mg supply in South Africa.
Order Abacavir + Dolutegravir + Lamivudine 600mg/50mg/300mg
Hospitals, healthcare providers, pharmaceutical distributors and institutional buyers in South Africa can contact Global Pharma Trade to discuss requirements for Abacavir + Dolutegravir + Lamivudine 600mg/50mg/300mg.
When requesting a quotation, include the required quantity, destination city, buyer/importer details and documentation requirements. The supply proposal can then be reviewed according to product availability and applicable export and import regulations.
Frequently Asked Questions
What is Abacavir + Dolutegravir + Lamivudine 600mg/50mg/300mg?
It is a three-drug antiretroviral combination containing Abacavir 600mg, Dolutegravir 50mg and Lamivudine 300mg. The combination is also described as ABC + DTG + 3TC.
Who can purchase this medicine in South Africa?
Qualified pharmaceutical distributors, healthcare organizations, hospitals and other authorized procurement entities may source the product subject to applicable South African laws, regulatory requirements and authorization.
Can hospitals purchase Abacavir + Dolutegravir + Lamivudine in bulk?
Bulk procurement can be discussed with pharmaceutical suppliers. The required quantity, documentation, importer details and applicable regulatory requirements should be confirmed before an order is finalized.
Can this medicine be supplied from India to South Africa?
International pharmaceutical supply from India to South Africa may be possible subject to the applicable export requirements in India and import, authorization and regulatory requirements in South Africa.
Does SAHPRA regulate pharmaceutical imports into South Africa?
Yes. SAHPRA's regulatory framework covers medicines and pharmaceutical establishments, including applicable importation, distribution and licensing requirements.
How can I request a quotation?
Qualified buyers can provide the required quantity, destination in South Africa, importer/distributor information and documentation requirements to Global Pharma Trade for a supply discussion.
Conclusion
Abacavir + Dolutegravir + Lamivudine 600mg/50mg/300mg is a three-drug antiretroviral combination relevant to HIV treatment procurement. Global Pharma Trade supports enquiries from South African hospitals, healthcare providers, pharmaceutical distributors and institutional buyers seeking pharmaceutical supply from India.
For current availability, bulk requirements, documentation and shipment options, contact Global Pharma Trade with your procurement requirements. All supply remains subject to applicable pharmaceutical regulations, product authorization and import requirements in South Africa.